We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$63.3B
AUM Growth
+$192M
Cap. Flow
+$1.33B
Cap. Flow %
2.1%
Top 10 Hldgs %
14.31%
Holding
4,981
New
573
Increased
1,406
Reduced
1,427
Closed
1,256

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$561M
2
ACN icon
Accenture
ACN
+$435M
3
MRK icon
Merck
MRK
+$378M
4
NOC icon
Northrop Grumman
NOC
+$339M
5
V icon
Visa
V
+$308M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$439M
2
ZTS icon
Zoetis
ZTS
+$345M
3
MCD icon
McDonald's
MCD
+$343M
4
UNH icon
UnitedHealth
UNH
+$334M
5
SPGI icon
S&P Global
SPGI
+$279M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Industrials 11.25%
3 Healthcare 10.23%
4 Financials 10.22%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQXT icon
4551
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$152M
-1
Closed -$91
QRHC icon
4552
Quest Resource Holding
QRHC
$25.9M
-45,290
Closed -$389K
QRVO icon
4553
Qorvo
QRVO
$7.63B
-179,220
Closed -$20.6M
RARE icon
4554
Ultragenyx Pharmaceutical
RARE
$2.65B
-642
Closed -$30K
RBA icon
4555
RB Global
RBA
$20.8B
-50,388
Closed -$3.84M
RBLX icon
4556
Roblox
RBLX
$34B
-40,838
Closed -$1.56M
RCKT icon
4557
Rocket Pharmaceuticals
RCKT
$348M
-177,524
Closed -$4.78M
RDUS
4558
DELISTED
Radius Recycling
RDUS
-9,361
Closed -$198K
RDVI icon
4559
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
$3.48B
-1,928
Closed -$47.2K
RDZN icon
4560
Roadzen
RDZN
$101M
-3,920
Closed -$25.5K
REET icon
4561
iShares Global REIT ETF
REET
$5.12B
-21,477
Closed -$509K
REAX icon
4562
Real Brokerage
REAX
$368M
-16,231
Closed -$50.6K
REFR icon
4563
Research Frontiers
REFR
$16.1M
-1
Closed -$1
REGN icon
4564
CALL
Regeneron Pharmaceuticals
REGN
$68.8B
-2,600
Closed -$2.5M
REM icon
4565
iShares Mortgage Real Estate ETF
REM
$542M
-89,192
Closed -$2.07M
LNAI
4566
Lunai Bioworks
LNAI
$10.6M
-549
Closed -$116K
REPL icon
4567
Replimune Group
REPL
$814M
-221,222
Closed -$1.81M
RERE
4568
ATRenew
RERE
$859M
-1,794
Closed -$3.16K
REXR icon
4569
Rexford Industrial Realty
REXR
$8.7B
-640,322
Closed -$32.2M
RGEN icon
4570
Repligen
RGEN
$7.44B
-3,377
Closed -$621K
RIG icon
4571
Transocean
RIG
$5.92B
-749,676
Closed -$4.71M
RMD icon
4572
PUT
ResMed
RMD
$28.3B
-500
Closed -$99K
RNR icon
4573
RenaissanceRe
RNR
$13.7B
-51,099
Closed -$12M
RODM icon
4574
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.58B
-28,900
Closed -$809K
ROIV icon
4575
Roivant Sciences
ROIV
$25.2B
-85,952
Closed -$906K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2024 Portfolio in Review

As of Q2 2024, Qube Research & Technologies (QRT) held 4,981 positions worth $63.3B, up 0.3% from $63.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT)'s Q2 2024 filing shows 573 new, 1,406 increased, 1,427 reduced and 1,256 closed positions. Its largest new stake was Coinbase: 273,144 shares worth $60.7M. The largest sale was NVIDIA, an estimated $439M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q2 2024 buy was Coinbase: 273,144 shares worth $60.7M.
  • Qube Research & Technologies (QRT) added most to Broadcom in Q2 2024, an estimated $561M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $439M.
  • Qube Research & Technologies (QRT) fully exited Palantir in Q2 2024, selling an estimated $161M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $63.3B portfolio in Q2 2024.
  • Qube Research & Technologies (QRT) opened 573 new positions and closed 1,256 in Q2 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.3% quarter-over-quarter to $63.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.